This inventor holds 4 USPTO granted patents. Top assignees: Ciba-Geigy Corporation, Novartis Ag. Active years: 1993-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Rhode-St-Genese, BE (1993 - 1999)
- Rhode-St-Genèse, BE (2002)
Company Filing History:
Years Active: 1993-2002
Title: The Innovations of Jean Content
Introduction
Jean Content is a notable inventor based in Rhode-St-Genese, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of proteins and antibodies related to interferon therapy. With a total of 4 patents, his work has implications for antiviral treatments and diagnostic tools.
Latest Patents
Jean Content's latest patents include groundbreaking inventions such as "Interferon-induced human protein in pure form, monoclonal antibodies thereto and test kits containing these antibodies." This invention focuses on purified proteins induced in human cells by interferon alpha or beta, along with the associated RNAs, DNAs, and hybrid vectors coding for these proteins. The patent also covers processes for the preparation and purification of these proteins, as well as the development of monoclonal antibodies specific to these proteins. These antibodies and their derivatives are crucial for the qualitative and quantitative determination of the proteins, and they are incorporated into test kits and pharmaceutical preparations. The proteins developed show antiviral properties attributed to interferons and serve as valuable indicators of cellular responses to interferon therapy.
Career Highlights
Throughout his career, Jean Content has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Ciba-Geigy Corporation. His experience in these organizations has allowed him to advance his research and contribute to significant innovations in the field.
Collaborations
Jean Content has collaborated with esteemed colleagues such as Michel A. Horisberger and Heinz-Kurt Hochkeppel. These partnerships have fostered a collaborative environment that has enhanced the development of his inventions.
Conclusion
Jean Content's contributions to biotechnology through his patents and collaborations have made a lasting impact on the field. His work continues to influence the development of antiviral therapies and diagnostic tools, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile